España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sonnet BioTherapeutics
SONN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.89
-0.03
-1.03%
At close: -
$2.95
0.06
2.08%
After Hours: 9:29 AM EDT
Get Report
Comment
Sonnet BioTherapeutics (SONN) Forecast
News
Earnings
Sonnet BioTherapeutics (SONN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sonnet BioTherapeutics (NASDAQ:SONN) Stock
Sonnet BioTherapeutics Stock (NASDAQ: SONN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
Sonnet BioTherapeutics Prices $5M Public Offe...
Benzinga Newsdesk
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Dow Jumps Over 1,200 Points; Donald Trump Wins White House
Avi Kapoor
Sonnet BioTherapeutics Shares Resume Trading
Benzinga Newsdesk
Sonnet BioTherapeutics Shares Halted On Circu...
Benzinga Newsdesk
Sonnet BioTherapeutics Shares Resume Trade
Benzinga Newsdesk
Sonnet BioTherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet BioTherapeutics Shares Halted On Circu...
Benzinga Newsdesk
Sonnet BioTherapeutics Announces Issuance Of ...
Benzinga Newsdesk
Monday, October 28, 2024
Sonnet BioTherapeutics shares are trading low...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views
Avi Kapoor
Sonnet Biotherapeutics Files To Sell Common S...
Benzinga Newsdesk
Thursday, October 17, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Sonnet BioTherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet BioTherapeutics Regains Compliance Wit...
Benzinga Newsdesk
Wednesday, October 09, 2024
Sonnet BioTherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet BioTherapeutics Enters Licensing Agree...
Benzinga Newsdesk
Friday, October 04, 2024
Sonnet Received Approval Of Its Application T...
Benzinga Newsdesk
Friday, September 27, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, September 26, 2024
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, September 25, 2024
Why Sonnet BioTherapeutics (SONN) Shares Are Down 19% Today
Henry Khederian
Sonnet BioTherapeutics shares are trading low...
Benzinga Newsdesk
Sonnet BioTherapeutics To Effect 1-For-8 Reve...
Benzinga Newsdesk
Wednesday, September 18, 2024
Sonnet BioTherapeutics Completes Enrollment I...
Benzinga Newsdesk
Friday, August 23, 2024
Chardan Capital Maintains Buy on Sonnet BioTh...
Benzinga Newsdesk
Monday, August 19, 2024
Sonnet BioTherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet BioTherapeutics Enters Into Clinical C...
Benzinga Newsdesk
Friday, August 16, 2024
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, August 15, 2024
Sonnet Biotherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet Biotherapeutics Filed U.S. Patent Appl...
Benzinga Newsdesk
Wednesday, August 14, 2024
Sonnet BioTherapeutics Q3 2024 GAAP EPS $(0.7...
Benzinga Newsdesk
Wednesday, July 24, 2024
Sonnet BioTherapeutics Reports Data From Phas...
Benzinga Newsdesk
Friday, June 21, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, June 20, 2024
Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher
Avi Kapoor
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Gold Rises 1%; Accenture Shares Surge After Q3 Results
Avi Kapoor
Sonnet BioTherapeutics shares are trading low...
Benzinga Newsdesk
Dow Edges Lower; US Current Account Deficit Widens In Q1
Avi Kapoor
Sonnet BioTherapeutics Announces Exercise Of ...
Benzinga Newsdesk
Thursday, June 13, 2024
Sonnet BioTherapeutics Announces Generation A...
Benzinga Newsdesk
Tuesday, May 28, 2024
Chardan Capital Maintains Buy on Sonnet BioTh...
Benzinga Newsdesk
Thursday, May 16, 2024
EF Hutton Maintains Buy on Sonnet BioTherapeu...
Benzinga Newsdesk
Monday, March 11, 2024
Sonnet BioTherapeutics shares are trading hig...
Benzinga Newsdesk
Sonnet BioTherapeutics Says Early Safety Data...
Benzinga Newsdesk
Thursday, February 29, 2024
Sonnet BioTherapeutics Reported SON-1010 Phas...
Charles Gross
Sonnet BioTherapeutics Announces A Publication Demonstrating Safety And Tolerability Of SON-1010 In Healthy Volunteers
Happy Mohamed
Thursday, February 15, 2024
Chardan Capital Maintains Buy on Sonnet BioTh...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch